<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Topical medication instillation techniques for glaucoma - Xu, L - 2017 | Cochrane Library</title> <meta content="Topical medication instillation techniques for glaucoma - Xu, L - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010520.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Topical medication instillation techniques for glaucoma - Xu, L - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010520.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010520.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Topical medication instillation techniques for glaucoma" name="citation_title"/> <meta content="Li Xu" name="citation_author"/> <meta content="Hainan Eye Hospital, Zhongshan Ophthalmic Center" name="citation_author_institution"/> <meta content="xuli-113@163.com" name="citation_author_email"/> <meta content="Xuemei Wang" name="citation_author"/> <meta content="Johns Hopkins Bloomberg School of Public Health" name="citation_author_institution"/> <meta content="Meijing Wu" name="citation_author"/> <meta content="Feinberg School of Medicine, Northwestern University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD010520.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/02/20" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010520.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010520.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010520.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Ophthalmic; Antihypertensive Agents [*administration &amp; dosage, adverse effects]; Bimatoprost [administration &amp; dosage]; Eyelashes [anatomy &amp; histology, drug effects]; Glaucoma [*drug therapy]; Intraocular Pressure [*drug effects]; Latanoprost; Ophthalmic Solutions [administration &amp; dosage, adverse effects]; Prostaglandins F, Synthetic [administration &amp; dosage]; Randomized Controlled Trials as Topic; Travoprost [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010520.pub2&amp;doi=10.1002/14651858.CD010520.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="UiM8QuvV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010520\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010520\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010520.pub2",title:"Topical medication instillation techniques for glaucoma",firstPublishedDate:"Feb 20, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010520.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010520.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010520.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010520.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010520.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010520.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010520.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010520.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010520.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010520.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3953 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010520.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-sec-0079"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-sec-0030"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-sec-0031"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-sec-0056"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-sec-0073"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/appendices#CD010520-sec-0083"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Topical medication instillation techniques for glaucoma</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/information#CD010520-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Li Xu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/information#CD010520-cr-0003">Xuemei Wang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010520.pub2/information#CD010520-cr-0004">Meijing Wu</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/information/en#CD010520-sec-0094">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 20 February 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010520.pub2">https://doi.org/10.1002/14651858.CD010520.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010520-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010520-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010520-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010520-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010520-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010520-abs-0001" lang="en"> <section id="CD010520-sec-0001"> <h3 class="title" id="CD010520-sec-0001">Background</h3> <p>Glaucoma is a leading cause of irreversible blindness worldwide and the second most common cause of blindness after cataracts. The primary treatment for glaucoma aims to lower intraocular pressure (IOP) with the use of topical medicines. Topical medication instillation techniques, such as eyelid closure and nasolacrimal occlusion when instilling drops, have been proposed as potential methods to increase ocular absorption and decrease systemic absorption of the drops. </p> </section> <section id="CD010520-sec-0002"> <h3 class="title" id="CD010520-sec-0002">Objectives</h3> <p>To investigate the effectiveness of topical medication instillation techniques compared with usual care or another method of instillation of topical medication in the management of glaucoma or ocular hypertension. </p> </section> <section id="CD010520-sec-0003"> <h3 class="title" id="CD010520-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) (2016, Issue 12), MEDLINE Ovid (1946 to 8 December 2016), Embase Ovid (1947 to 8 December 2016), PubMed (1948 to 8 December 2016), LILACS (Latin American and Caribbean Health Sciences Literature Database) (1982 to 8 December 2016), International Pharmaceutical Abstracts Database (1970 to 8 December 2016), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>) (last searched 13 May 2013), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>) (searched 8 December 2016) and the WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>) (searched 8 December 2016). We did not use any date or language restrictions in the electronic searches for trials. </p> </section> <section id="CD010520-sec-0004"> <h3 class="title" id="CD010520-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials which had compared any topical medication instillation technique with usual care or a different method of instillation of topical medication. </p> </section> <section id="CD010520-sec-0005"> <h3 class="title" id="CD010520-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened records from the searches for eligibility, assessed the risk of bias, and extracted data. We followed methods recommended by Cochrane. </p> </section> <section id="CD010520-sec-0006"> <h3 class="title" id="CD010520-sec-0006">Main results</h3> <p>We identified two trials (122 eyes of 61 participants) that had evaluated a topical medication instillation technique. We also identified two ongoing trials. Both included trials used a within‐person design and administered prostaglandin monotherapy for glaucoma or ocular hypertension. Because the trials evaluated different instillation techniques and assessed different outcomes, we performed no meta‐analysis. </p> <p>One trial, conducted in the US, evaluated the effect of eyelid closure (one and three minutes) versus no eyelid closure on lowering IOP. At one to two weeks' follow‐up, reduction in IOP was similar in the eyelid closure group and the no eyelid closure group (mean difference (MD) ‐0.33 mmHg, 95% confidence interval (CI) ‐0.8 to 1.5; 51 participants; moderate‐certainty evidence). </p> <p>The second trial, conducted in Italy, evaluated the effect of using an absorbent cloth to wipe excess fluid after instillation (fluid removal) versus not using an absorbent cloth (no removal) on reducing dermatologic adverse events. At four months' follow‐up, eyelashes were shorter among eyes in the fluid removal group compared with the no fluid removal group (MD ‐1.70 mm, 95% CI ‐3.46 to 0.06; 10 participants; low‐certainty evidence). Fewer eyes showed skin hyperpigmentation in the eyelid region towards the nose in the fluid removal group compared with the no removal group (RR 0.07, 95% CI 0.01 to 0.84; 10 participants; low‐certainty evidence); however, the difference was uncertain in the eyelid region towards the temples (RR 0.44, 95% CI 0.07 to 2.66; 10 participants; low‐certainty evidence). The effect hypertrichosis (excessive hair growth) was uncertain between groups (RR 1.00, 95% CI 0.17 to 5.98; 10 participants; low‐certainty evidence). </p> <p>Neither trial reported other outcomes specified for this review, including the proportion of participants with IOP less than 21 mmHg; participant‐reported outcomes related to the ease, convenience, and comfort of instillation techniques; physiologic measurements of systemic absorption; escalation of therapy; mean change in visual fields; optic nerve progression; mean change in best‐corrected visual acuity; proportion in whom glaucoma developed; quality of life outcomes; or cost‐effectiveness outcomes. Neither trial reported data at follow‐up times of more than four months. </p> </section> <section id="CD010520-sec-0007"> <h3 class="title" id="CD010520-sec-0007">Authors' conclusions</h3> <p>Evidence to evaluate the effectiveness of topical medication instillation techniques for treatment of glaucoma is lacking. It is unclear what, if any, effects instillation techniques have on topical medical therapy for glaucoma. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010520-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010520-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010520-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010520-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010520-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010520-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010520-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010520-abs-0003" lang="en"> <h3>Topical medicine instillation techniques for glaucoma</h3> <p><b>What is the aim of this review?</b> <br/> The aim of this Cochrane Review was to find out if the way that people with glaucoma put eye drops in makes a difference in how well the eye drops work. Cochrane researchers collected and analyzed all relevant studies to answer this question and found two studies. </p> <p><b>Key messages</b> <br/> It is unclear if the way that people with glaucoma put their eye drops in makes a difference in how well the drops work. </p> <p><b>What did this review study?</b> <br/> Glaucoma is a leading cause of blindness worldwide. In eyes with glaucoma, the ability to see may be lost because of damage to the optic nerve. The optic nerve is the part of the eye that sends visual information from the eye to the brain. Sometimes such damage occurs when there is too much pressure in the eye (called intraocular pressure or IOP). Sometimes eyes may have too much pressure without damage to the optic nerve (called ocular hypertension). The main goal of glaucoma and ocular hypertension treatment is to lower IOP. Topical medicines, such as eye drops, are most often used as the first treatment. Encouraging specific ways of applying the drops, such as closing your eyes or nasolacrimal occlusion (closing the eye and pressing a finger on the inside corner, by the nose) aims to increase how much medicine is absorbed into the eye and reduce how much medicine is absorbed into the body. </p> <p><b>What are the main results of the review?</b> <br/> We found two studies that compared different ways of putting in eye drops. Both studies used prostaglandin alone for glaucoma or ocular hypertension. One study, in the US, evaluated the effect of closing the eyes for one and three minutes after putting in eye drops on lowering IOP. The second study, in Italy, looked at whether wiping off the excess fluid, after putting in the eye drops, led to fewer changes in the skin surrounding the eye. </p> <p>After one to two weeks in the US study, closing the eyelid for one to three minutes after putting in the eye drops found no difference on IOP compared with not closing the eyelid for a specified amount of time. After four months in the Italian study, eyelashes were shorter when participants had wiped their eyes to remove excess fluid when compared with participants who did not wipe their eyes. </p> <p>We found two ongoing studies that do not have results yet.</p> <p>Based on only two studies and uncertain results, it is unclear if different ways of putting in eye drops have any effect on people with glaucoma. </p> <p><b>How up‐to‐date is this review?</b> <br/> Cochrane researchers searched for studies that had been published up to 8 December 2016. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010520-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010520-sec-0079"></div> <h3 class="title" id="CD010520-sec-0080">Implications for practice</h3> <section id="CD010520-sec-0080"> <p>This review identified a paucity of evidence to inform robust conclusions for topical instillation techniques treating glaucoma in practice. </p> <p>One study of participants receiving chronic bilateral prostaglandin monotherapy randomized one eye to eyelid closure (ELC), while the fellow eye served as within‐person control, provided moderate‐certainty evidence of a minimal difference between the ELC group and the no ELC group with respect to intraocular pressure (IOP) change from baseline. In another study, participants were instructed to wipe one eye with an absorbent pad after administration of prostaglandin eye drops. The fellow eye acted as the within‐person control and was not wiped. There was a reduction of the incidence and extent of dermatologic adverse events in the nasal region; however, this difference was not observed in the temporal region. The results from these small studies should be interpreted cautiously as these data represent only two types of instillation techniques and these results are not necessarily applicable to other antiglaucoma topical agents. </p> </section> <h3 class="title" id="CD010520-sec-0081">Implications for research</h3> <section id="CD010520-sec-0081"> <p>There is a need for well‐designed and adequately powered parallel‐group RCTs to determine:</p> <p> <ul id="CD010520-list-0006"> <li> <p>whether topical instillation techniques aimed at increasing ocular absorption of drops can enhance the IOP‐lowering effect of most antiglaucoma agents; </p> </li> <li> <p>which topical instillation technique is favorable over others to enhance IOP‐lowering effects; </p> </li> <li> <p>whether the topical instillation techniques aimed at reducing systemic absorption of drops or obstructing the medicine into the nasopharyngeal mucosa can minimize local or systemic adverse events. </p> </li> </ul> </p> <p>In order to enroll a sufficiently large and diverse sample size, future randomized controlled trials should be multi‐centered with a central coordinating center to ensure adherence to methodologic standards and consistency of protocols is maintained across all study sites. Although masking of participants and some study personnel are not feasible, using a parallel‐group rather than paired‐eye design could minimize potential cross‐over effects and performance bias. Outcome assessors should remain masked to treatment assignments until the trial ends and data have been analyzed. In addition to IOP change as a primary outcome of interest, other clinical and participant‐centered outcomes should be assessed, such as changes in visual field parameters, best‐corrected visual acuity, participant‐reported outcomes related to the ease, convenience and comfort of instillation techniques, and adverse events. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010520-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010520-sec-0022"></div> <div class="table" id="CD010520-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Topical medication instillation techniques for glaucoma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Topical medication instillation techniques for glaucoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> participants with glaucoma or ocular hypertension </p> <p><b>Settings:</b> ophthalmology clinics </p> <p><b>Intervention:</b> any intervention aimed to increase effectiveness or reduce adverse events when using topical medications (e.g. eyelid closure, nasolacrimal occlusion, removal of excess fluid after instillation) </p> <p><b>Comparison:</b> no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No intervention</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Instillation intervention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants with IOP &lt; 21 mmHg</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean IOP change from baseline</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 trial reported that reduction of IOP was similar in eyes when the eyelid was kept closed for up to 3 minutes after instillation of drops than fellow eyes that did not practice eyelid closure at 2 weeks (MD ‐0.33 mmHg, 95% CI ‐0.8 to 1.5; 51 participants); moderate‐certainty evidence.<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported outcomes related to the ease, convenience, and comfort of instillation</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physiologic measurements of systemic absorption</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Escalation of therapy</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in visual fields</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 trial with up to 4 months' follow‐up reported that eyelashes were shorter among eyes when participants had wiped to remove excess fluid compared with fellow eyes that were not wiped (MD ‐1.70 mm, 95% CI ‐3.46 to 0.06; 10 participants) and fewer eyes had eyelash growth of &gt; 1.5 mm when wiping compared with not wiping (RR 0.11, 95% CI 0.01 to 1.24); low‐certainty evidence.<sup>1,2</sup> </p> <p>This same trial also reported that fewer eyes showed skin hyperpigmentation in the eyelid region towards the nose when wiping compared with not wiping (RR 0.07, 95% CI 0.01 to 0.84); however, the difference was not certain when assessing skin hyperpigmentation in the eyelid region towards the temples (RR 0.44, 95% CI 0.07 to 2.66) or hair growth on the skin around the eye (RR 1.00, 95% CI 0.17 to 5.98); low‐certainty evidence.<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the control group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>MD:</b> mean difference; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for risk of performance, detection bias, or both.<br/> <sup>2</sup>Downgraded one level for imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010520-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010520-sec-0023"></div> <section id="CD010520-sec-0024"> <h3 class="title" id="CD010520-sec-0024">Description of the condition</h3> <p>Glaucoma is a chronic, progressive optic neuropathy. If left undiagnosed and untreated, the optic nerve of people with glaucoma may sustain irreversible damage (<a href="./references#CD010520-bbs2-0058" title="LeeDA , HigginbothamEJ . Glaucoma and its treatment: a review. American Journal of Health‐System Pharmacy2005;62(7):691‐9. ">Lee 2005</a>). At the end stage, people have permanent visual field loss and blindness (<a href="./references#CD010520-bbs2-0061" title="MarquisRE , WhitsonJT . Management of glaucoma: focus on pharmacological therapy. Drugs and Aging2005;22(1):1‐21. ">Marquis 2005</a>). </p> <p>Factors associated with increased risk for the development of glaucoma include elevated intraocular pressure (IOP), increasing age, a positive family history of glaucoma, African or Asian racial background, near‐sightedness, and thinner central corneal thickness (<a href="./references#CD010520-bbs2-0033" title="AlsbirkPH . Primary angle‐closure glaucoma: oculometry, epidemiology, and genetics in a high risk population. Acta Ophthalmologica Supplementum1976;127:5‐31. ">Alsbirk 1976</a>; <a href="./references#CD010520-bbs2-0034" title="ArmalyMF , KruegerDE , MaunderL , BeckerB , HetheringtonJJr , KolkerAE , et al. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual‐field defects. Archives of Ophthalmology1980;98(12):2163‐71. ">Armaly 1980</a>; <a href="./references#CD010520-bbs2-0040" title="ColemanAL , MigliorS . Risk factors for glaucoma onset and progression. Survey of Ophthalmology2008;53(6):S3‐10. ">Coleman 2008</a>; <a href="./references#CD010520-bbs2-0044" title="ErnestPJ , SchoutenJS , BeckersHJ , HendrikseF , PrinsMH , WebersCA . An evidence‐based review of prognostic factors for glaucomatous visual field progression. Ophthalmology2013;120(3):512‐9. ">Ernest 2013</a>; <a href="./references#CD010520-bbs2-0055" title="LandersJ , GoldbergI , GrahamSL . Analysis of risk factors that may be associated with progression from ocular hypertension to primary open angle glaucoma. Clinical and Experimental Ophthalmology2002;30(4):242‐7. ">Landers 2002</a>; <a href="./references#CD010520-bbs2-0056" title="LeA , MukeshBN , McCartyCA , TaylorHR . Risk factors associated with the incidence of open‐angle glaucoma: the visual impairment project. Investigative Ophthalmology and Visual Science2003;44(9):3783‐9. ">Le 2003</a>; <a href="./references#CD010520-bbs2-0063" title="MedeirosFA , SamplePA , ZangwillLM , BowdC , AiharaM , WeinrebRN . Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. American Journal of Ophthalmology2003;136(5):805‐13. ">Medeiros 2003</a>; <a href="./references#CD010520-bbs2-0074" title="TielschJM . The epidemiology and control of open angle glaucoma: a population‐based perspective. Annual Review of Public Health1996;17:121‐36. ">Tielsch 1996</a>). Elevated IOP is viewed as a major risk factor of glaucoma rather than a defining feature of the condition because elevated IOP and glaucomatous optic neuropathy (GON) do not necessarily coexist (<a href="./references#CD010520-bbs2-0038" title="CassonRJ , ChidlowG , WoodJP , CrowstonJG , GoldbergI . Definition of glaucoma: clinical and experimental concepts. Clinical and Experimental Ophthalmology2012;40(4):341‐9. ">Casson 2012</a>). Additionally, IOP is the only known risk factor that can be modified. </p> <section id="CD010520-sec-0025"> <h4 class="title">Epidemiology of glaucoma</h4> <p>Glaucoma is a significant public health problem as it is the leading cause of irreversible blindness worldwide and the second most common cause of blindness after cataracts (<a href="./references#CD010520-bbs2-0050" title="HeijlA , BengtssonB , HymanL , LeskeMC , Early Manifest Glaucoma Trial Group. Natural history of open‐angle glaucoma. Ophthalmology2009;116(12):2271‐6. ">Heijl 2009</a>; <a href="./references#CD010520-bbs2-0065" title="PanY , VarmaR . Natural history of glaucoma. Indian Journal of Ophthalmology2011;59(Suppl):S19‐23. ">Pan 2011</a>; <a href="./references#CD010520-bbs2-0066" title="QuigleyHA . Number of people with glaucoma worldwide. British Journal of Ophthalmology1996;80(5):389‐93. ">Quigley 1996</a>). In 2014, Tham and colleagues estimated that 3.54% of people in the world between the ages of 40 to 80 years had glaucoma and projected that the worldwide prevalence of glaucoma would be 76.0 million in 2020 and 111.8 million people in 2040 (<a href="./references#CD010520-bbs2-0073" title="ThamYC , LiX , WongTY , QuigleyHA , AungT , ChengCY . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta‐analysis. Ophthalmology2014;121(11):2081‐90. ">Tham 2014</a>). An earlier study projected the number of people bilaterally blind from primary glaucoma would to be more than 11.2 million by 2020 (<a href="./references#CD010520-bbs2-0067" title="QuigleyHA , BromanAT . The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology2006;90(3):262‐7. ">Quigley 2006</a>). In the US, 10% of people who are bilaterally blind are believed to be blind secondary to glaucoma (<a href="./references#CD010520-bbs2-0041" title="CongdonN , O'ColmainB , KlaverCC , KleinR , MuñozB , Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Archives of Ophthalmology2004;122(4):477‐85. ">Congdon 2004</a>). Primary open‐angle glaucoma (POAG) is the most common type of glaucoma, accounting for 74% of all persons with glaucoma (<a href="./references#CD010520-bbs2-0066" title="QuigleyHA . Number of people with glaucoma worldwide. British Journal of Ophthalmology1996;80(5):389‐93. ">Quigley 1996</a>). </p> </section> <section id="CD010520-sec-0026"> <h4 class="title">Glaucoma treatment</h4> <p>Because no treatment has been proven to repair or regenerate a damaged optic nerve, the primary purpose of glaucoma therapy is to manage IOP to a target level at which progressive GON and vision loss are stopped or delayed (<a href="./references#CD010520-bbs2-0058" title="LeeDA , HigginbothamEJ . Glaucoma and its treatment: a review. American Journal of Health‐System Pharmacy2005;62(7):691‐9. ">Lee 2005</a>). IOP reduction is the only current evidence‐based treatment strategy for all types of glaucoma, including normal tension glaucoma (<a href="./references#CD010520-bbs2-0038" title="CassonRJ , ChidlowG , WoodJP , CrowstonJG , GoldbergI . Definition of glaucoma: clinical and experimental concepts. Clinical and Experimental Ophthalmology2012;40(4):341‐9. ">Casson 2012</a>). In general, three main treatments for glaucoma are directed toward reducing IOP: medical therapy, laser therapy, and incisional surgery. Although each of these types of treatments is effective in lowering IOP to some extent, therapy usually begins with medications. To reduce IOP further to a target level, medications can be used as supplemental treatment with laser or surgery when laser or surgery alone is not successful in reaching the target postoperative IOP. </p> <p>The mechanics of medications in lowering IOP involve reducing aqueous humor production or increasing the rate of outflow of aqueous humor within the eye. For most people, one or more topical medications are effective in reducing IOP. Many medical treatments, usually applied topically, are available for this purpose (e.g. prostaglandin analogs, beta‐blockers, alpha2‐selective adrenergic agonists, cholinergic agonists, and carbonic anhydrase inhibitors) (<a href="./references#CD010520-bbs2-0064" title="NoeckerRJ . The management of glaucoma and intraocular hypertension: current approaches and recent advances. Therapeutics and Clinical Risk Management2006;2(2):193‐206. ">Noecker 2006</a>). </p> </section> </section> <section id="CD010520-sec-0027"> <h3 class="title" id="CD010520-sec-0027">Description of the intervention</h3> <p>Many topical antiglaucoma medications are associated with systemic adverse events. For example, beta‐blockers have been associated with arrhythmias, congestive cardiac failure, and airway obstruction (<a href="./references#CD010520-bbs2-0042" title="EhongoA , BremerF . Ocular side effects of glaucoma treatment agents. Bulletin de la Societe Belge d Ophtalmologie2007;304:103‐10. ">Ehongo 2007</a>); and carbonic anhydrase inhibitors may cause thrombocytopenia (<a href="./references#CD010520-bbs2-0035" title="BeckersHJ , SchoutenJS , WebersCA , van derValkR , HendrikseF . Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(10):1485‐90. ">Beckers 2008</a>; <a href="./references#CD010520-bbs2-0037" title="CantorLB . Systemic side effects of glaucoma medications. Indiana Medicine1989;82(2):105‐7. ">Cantor 1989</a>). There also are concerns related to local side effects. For example, prostaglandins have been associated with undesired eye lash growth, pigmentation of the iris (colored part of the eye), and darkening of skin around the eyes (<a href="./references#CD010520-bbs2-0072" title="SmithS , FagienS , WhitcupSM , LedonF , SomogyiC , WengE , et al. Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double‐masked, vehicle‐controlled, parallel‐group study. Journal of the American Academy of Dermatology2012;66(5):801‐6. ">Smith 2012</a>). To increase the therapeutic index of antiglaucoma medications (i.e. to increase the desired therapeutic effect while reducing the undesired adverse events), various techniques for applying medications topically have been suggested (<a href="./references#CD010520-bbs2-0028" title="ZimmermanTJ , KoonerKS , KandarakisAS , ZieglerLP . Improving the therapeutic index of topically applied ocular drugs. Archives of Ophthalmology1984;102(4):551‐3. ">Zimmerman 1984</a>). Examples of topical medication instillation techniques include eyelid closure (ELC), nasolacrimal (tear drainage) occlusion (NLO), changes in the proximity of the eye‐dropper tip to the eyes (contact versus no contact), instillation of drops into the conjunctival sac, removal of excess fluid after instillation, and delayed time interval between instillation of multiple topical medications. These techniques are designed to improve ocular bioavailability and to lower systemic absorption of the drug during instillation of topical medications to achieve the goal of increasing the therapeutic index (<a href="./references#CD010520-bbs2-0036" title="BourlaisCL , AcarL , ZiaH , SadoPA , NeedhamT , LevergeR . Ophthalmic drug delivery systems ‐ recent advances. Progress in Retinal and Eye Research1998;17(1):33‐58. ">Bourlais 1998</a>; <a href="./references#CD010520-bbs2-0070" title="ShellJW . Ophthalmic drug delivery systems. Survey of Ophthalmology1984;29(2):117‐28. ">Shell 1984</a>; <a href="./references#CD010520-bbs2-0076" title="ZimmermanTJ , ZaltaAH . Facilitating patient compliance in glaucoma therapy. Survey of Ophthalmology1983;28(Suppl):252‐8. ">Zimmerman 1983</a>). ELC involves gently closing the eyes for several minutes after the medication is applied, to prolong eye‐drug contact and to block drainage of the drug into the nasopharyngeal mucosa. NLO is achieved by applying pressure over the area between the bridge of the nose and the inner canthus, known as the periphery of the nasolacrimal drainage system, to block tear drainage. </p> </section> <section id="CD010520-sec-0028"> <h3 class="title" id="CD010520-sec-0028">How the intervention might work</h3> <p>When ocular medications are instilled topically, some medication may spill out of the eye or may not be completely absorbed by the target area. Some studies have suggested that as much as 90% of topical eye drops is wasted or is not absorbed intraocularly (<a href="./references#CD010520-bbs2-0039" title="ChangSC , ChienDS , BundgaardH , LeeVH . Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol. Experimental Eye Research1988;46(1):59‐69. ">Chang 1988</a>; <a href="./references#CD010520-bbs2-0049" title="GuptaR , PatilB , ShahBM , BaliSJ , MishraSK , DadaT . Evaluating eye drop instillation technique in glaucoma patients. Journal of Glaucoma2012;21(3):189‐92. ">Gupta 2012</a>; <a href="./references#CD010520-bbs2-0057" title="LeeVH , RobinsonJR . Topical ocular drug delivery: recent developments and future challenges. Journal of Ocular Pharmacology1986;2(1):67‐108. ">Lee 1986</a>). When drug absorption into the eye is limited, most of the medication is absorbed into the nasopharyngeal mucosa through the nasolacrimal duct. With increased contact time between topically applied medicine and the ocular surface, and with obstruction of drainage of the medicine into the nasopharyngeal mucosa, intraocular medicine concentrations may be increased. When more of the medicine remains available locally, a greater number of medicine molecules may reach the intended intraocular receptors, increasing the desired ocular effects, and fewer medicine molecules may reach the circulatory system, decreasing undesired adverse events through systemic absorption. Numerous reports have described cardiovascular and respiratory complications associated with timolol, a widely used nonselective beta‐antagonist antiglaucoma medication, since its introduction in 1978 (<a href="./references#CD010520-bbs2-0054" title="KatzIM . Side effects of topical ocular timolol. American Journal of Ophthalmology1983;96(4):552‐3. ">Katz 1983</a>; <a href="./references#CD010520-bbs2-0059" title="LevineL . Clinical implications of reported timolol‐induced side effects. American Journal of Optometry and Physiological Optics1982;59(6):523‐8. ">Levine 1982</a>; <a href="./references#CD010520-bbs2-0075" title="ZimmermanTJ , LeaderBJ , GolobDS . Potential side effects of timolol therapy in the treatment of glaucoma. Annals of Ophthalmology1981;13(6):683‐9. ">Zimmerman 1981</a>). Topical medication instillation techniques have been reported not only to reduce systemic timolol absorption (<a href="./references#CD010520-bbs2-0053" title="KailaT , HuupponenR , SalminenL . Effects of eyelid closure and nasolacrimal duct occlusion on the systemic absorption of ocular timolol in human subjects. Journal of Ocular Pharmacology1986;2(4):365‐9. ">Kaila 1986</a>; <a href="./references#CD010520-bbs2-0019" title="PassoMS , PalmerEA , VanBuskirkEM . Plasma timolol in glaucoma patients. Ophthalmology1984;91(11):1361‐3. ">Passo 1984</a>; <a href="./references#CD010520-bbs2-0028" title="ZimmermanTJ , KoonerKS , KandarakisAS , ZieglerLP . Improving the therapeutic index of topically applied ocular drugs. Archives of Ophthalmology1984;102(4):551‐3. ">Zimmerman 1984</a>) but also to enhance ocular penetration of the medicine (<a href="./references#CD010520-bbs2-0043" title="EllisPP , WuPY , PfoffDS , BloedowDC , RiegelMR . Effect of nasolacrimal occlusion on timolol concentrations in the aqueous humor of the human eye. Journal of Pharmaceutical Sciences1992;81(3):219‐20. ">Ellis 1992</a>; <a href="./references#CD010520-bbs2-0045" title="FraunfelderFT . Extraocular fluid dynamics: how best to apply topical ocular medication. Transactions of the American Ophthalmological Society1976;74:457‐87. ">Fraunfelder 1976</a>; <a href="./references#CD010520-bbs2-0028" title="ZimmermanTJ , KoonerKS , KandarakisAS , ZieglerLP . Improving the therapeutic index of topically applied ocular drugs. Archives of Ophthalmology1984;102(4):551‐3. ">Zimmerman 1984</a>). </p> </section> <section id="CD010520-sec-0029"> <h3 class="title" id="CD010520-sec-0029">Why it is important to do this review</h3> <p>Various topical medication instillation techniques have been recommended for administering ocular treatments. Some studies suggest that NLO or ELC may enhance intraocular absorption (<a href="./references#CD010520-bbs2-0043" title="EllisPP , WuPY , PfoffDS , BloedowDC , RiegelMR . Effect of nasolacrimal occlusion on timolol concentrations in the aqueous humor of the human eye. Journal of Pharmaceutical Sciences1992;81(3):219‐20. ">Ellis 1992</a>; <a href="./references#CD010520-bbs2-0045" title="FraunfelderFT . Extraocular fluid dynamics: how best to apply topical ocular medication. Transactions of the American Ophthalmological Society1976;74:457‐87. ">Fraunfelder 1976</a>; <a href="./references#CD010520-bbs2-0028" title="ZimmermanTJ , KoonerKS , KandarakisAS , ZieglerLP . Improving the therapeutic index of topically applied ocular drugs. Archives of Ophthalmology1984;102(4):551‐3. ">Zimmerman 1984</a>), reduce systemic absorption (<a href="./references#CD010520-bbs2-0053" title="KailaT , HuupponenR , SalminenL . Effects of eyelid closure and nasolacrimal duct occlusion on the systemic absorption of ocular timolol in human subjects. Journal of Ocular Pharmacology1986;2(4):365‐9. ">Kaila 1986</a>; <a href="./references#CD010520-bbs2-0019" title="PassoMS , PalmerEA , VanBuskirkEM . Plasma timolol in glaucoma patients. Ophthalmology1984;91(11):1361‐3. ">Passo 1984</a>; <a href="./references#CD010520-bbs2-0028" title="ZimmermanTJ , KoonerKS , KandarakisAS , ZieglerLP . Improving the therapeutic index of topically applied ocular drugs. Archives of Ophthalmology1984;102(4):551‐3. ">Zimmerman 1984</a>), or both, of topically applied glaucoma medications. However, it is unclear whether reducing systemic absorption or enhancing intraocular absorption leads to an increased therapeutic effect of medication (<a href="./references#CD010520-bbs2-0071" title="SleathB , BlalockS , CovertD , StoneJL , SkinnerAC , MuirK , et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology2011;118(12):2398‐402. ">Sleath 2011</a>). Because of these controversies, it is necessary to review and summarize data regarding instillation techniques for their effectiveness, feasibility, and practicality systematically. However, to date no such review has been published (<a href="./references#CD010520-bbs2-0060" title="LiT , VedulaSS , SchererR , DickersinK . What comparative effectiveness research is needed? A framework for using guidelines and systematic reviews to identify evidence gaps and research priorities. Annals of Internal Medicine2012;156(5):367‐77. ">Li 2012</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010520-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010520-sec-0030"></div> <p>To investigate the effectiveness of topical medication instillation techniques compared with usual care or another method of instillation of topical medication in the management of glaucoma or ocular hypertension. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010520-sec-0031" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010520-sec-0031"></div> <section id="CD010520-sec-0032"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010520-sec-0033"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs).</p> </section> <section id="CD010520-sec-0034"> <h4 class="title">Types of participants</h4> <p>We included RCTs of participants who had been prescribed topical eye medication for the treatment or control of glaucoma, including POAG, primary angle‐closure glaucoma (PACG), and secondary glaucomas (such as pigmentary glaucoma or pseudoexfoliative glaucoma). We also included studies of participants with ocular hypertension or suspected to have glaucoma. </p> </section> <section id="CD010520-sec-0035"> <h4 class="title">Types of interventions</h4> <p>We included RCTs that had compared topical medication instillation techniques with usual care or another method of instillation of topical medication. Topical medication instillation techniques may have included ELC, NLO, making sure the dropper does not touch the ocular area, instillation of drops into the conjunctival sac, removal of excess fluid after instillation, and delayed time interval between instillation of multiple topical medications. </p> </section> <section id="CD010520-sec-0036"> <h4 class="title">Types of outcome measures</h4> <section id="CD010520-sec-0037"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010520-list-0001"> <li> <p>Reduction of IOP from baseline measured as the:</p> <ul id="CD010520-list-0002"> <li> <p>proportion of participants with IOP less than 21 mmHg at one year;</p> </li> <li> <p>mean IOP change from baseline at one year.</p> </li> </ul> </li> </ul> </p> </section> <section id="CD010520-sec-0038"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010520-list-0003"> <li> <p>Participant‐reported outcomes related to the ease, convenience, and comfort of instillation techniques </p> </li> <li> <p>Physiologic measurements of systemic absorption</p> </li> <li> <p>Escalation of therapy (such as added medications, laser trabeculoplasty, surgery, or a combination of these). </p> </li> <li> <p>Mean change in IOP</p> </li> <li> <p>Mean change in visual fields (mean deviation)</p> </li> <li> <p>Optic nerve progression (measured by mean change in cup/disk ratio)</p> </li> <li> <p>Mean change in best‐corrected visual acuity</p> </li> <li> <p>Development of glaucoma among baseline glaucoma suspects or ocular hypertensive medications at three months, six months, one year, and subsequent years of follow‐up. </p> </li> <li> <p>Quality of life outcomes.</p> </li> <li> <p>Cost‐effectiveness outcomes.</p> </li> <li> <p>Adverse events.</p> </li> </ul> </p> <section id="CD010520-sec-0039"> <h6 class="title">Adverse events</h6> <p>We documented and compared ocular and systemic adverse events. Commonly reported ocular and systemic adverse events for various glaucoma drug classes are shown in <a href="#CD010520-tbl-0002">Table 1</a>. </p> <div class="table" id="CD010520-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Commonly reported adverse events of medical glaucoma treatments</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Drug class</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Ocular adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Systemic adverse events</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Alpha‐agonists (e.g. apraclonidine, brimonidine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allergic reactions</p> <p>Blurred vision</p> <p>Burning/stinging/discomfort</p> <p>Follicular conjunctival response</p> <p>Hyperemia</p> <p>Itching</p> <p>Photophobia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allergic reactions</p> <p>Drowsiness</p> <p>Dry mouth</p> <p>Fatigue</p> <p>Headache</p> <p>Hypotension</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beta‐blockers (e.g. betaxolol, carteolol, levobunolol, timolol)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allergy</p> <p>Blurred vision</p> <p>Burning/stinging/discomfort</p> <p>Corneal erosion</p> <p>Dry eyes</p> <p>Hyperemia</p> <p>Hypotony</p> <p>Ptosis</p> <p>Superficial punctate keratitis</p> <p>Visual disturbances</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bradycardia</p> <p>Depression</p> <p>Dizziness or light‐headedness</p> <p>Fatigue</p> <p>Headache</p> <p>Indigestion or heart pain</p> <p>Insomnia</p> <p>Joint pain</p> <p>Nausea</p> <p>Shortness of breath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Carbonic anhydrase inhibitors (e.g. acetazolamide, brinzolamide, dorzolamide)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allergy</p> <p>Blurred vision</p> <p>Burning/stinging/discomfort</p> <p>Dry eyes</p> <p>Foreign body sensation</p> <p>Hyperemia</p> <p>Photophobia</p> <p>Superficial punctate keratitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allergic reactions</p> <p>Bitter or metallic taste</p> <p>Dizziness</p> <p>Fatigue</p> <p>Gastrointestinal distress</p> <p>Headache</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Parasympathomimetics (e.g. carbachol, pilocarpine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blurred vision</p> <p>Burning/stinging/discomfort</p> <p>Eyelid twitching</p> <p>Hyperemia</p> <p>Itching</p> <p>Increased tearing</p> <p>Poor vision in dim light</p> <p>Visual disturbances</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dizziness</p> <p>Headache</p> <p>Hypoglycemia</p> <p>Increased saliva</p> <p>Increased sweating</p> <p>Nausea</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prostaglandin analogues (e.g. bimatoprost, latanoprost, travoprost)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blurred vision</p> <p>Burning/stinging/discomfort</p> <p>Dry eyes</p> <p>Eyelash growth</p> <p>Foreign body sensation</p> <p>Hyperemia</p> <p>Increased tearing</p> <p>Iris/skin discoloration</p> <p>Itching</p> <p>Photophobia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cold symptoms</p> <p>Exacerbation of asthma</p> <p>Facial rash</p> <p>Joint or muscle pain</p> <p>Upper respiratory infection</p> </td> </tr> </tbody> </table> </div> </section> </section> </section> </section> <section id="CD010520-sec-0040"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010520-sec-0041"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Eyes and Vision Information Specialist conducted systematic searches in the following databases for RCTs. There were no language or publication year restrictions. The date of the search was 8 December 2016. </p> <p> <ul id="CD010520-list-0004"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 12) (which contains the Cochrane Eyes and Vision Trials Register) (searched 8 December 2016) (<a href="./appendices#CD010520-sec-0084">Appendix 1</a>); </p> </li> <li> <p>MEDLINE Ovid (1946 to 8 December 2016) (<a href="./appendices#CD010520-sec-0085">Appendix 2</a>); </p> </li> <li> <p>Embase Ovid (1980 to 8 December 2016) (<a href="./appendices#CD010520-sec-0086">Appendix 3</a>); </p> </li> <li> <p>PubMed (1948 to 8 December 2016) (<a href="./appendices#CD010520-sec-0087">Appendix 4</a>); </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database (1982 to 8 December 2016) (<a href="./appendices#CD010520-sec-0088">Appendix 5</a>); </p> </li> <li> <p>International Pharmaceutical Abstracts (1970 to 8 December 2016) (<a href="./appendices#CD010520-sec-0089">Appendix 6</a>); </p> </li> <li> <p><i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com" target="_blank">www.controlled‐trials.com</a>; last searched 13 May 2013) (<a href="./appendices#CD010520-sec-0090">Appendix 7</a>); </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 8 December 2016) (<a href="./appendices#CD010520-sec-0091">Appendix 8</a>); </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>; searched 8 December 2016) (<a href="./appendices#CD010520-sec-0092">Appendix 9</a>). </p> </li> </ul> </p> </section> <section id="CD010520-sec-0042"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of included studies for additional studies not identified by the electronic searches. We used the Science Citation Index (Web of Science) to search for additional studies that may have cited included studies. We did not handsearch journals or conference abstracts specifically for the purpose of this review. </p> </section> </section> <section id="CD010520-sec-0043"> <h3 class="title" id="CD010520-sec-0043">Data collection and analysis</h3> <section id="CD010520-sec-0044"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed titles and abstracts identified through the searches and classified each record as relevant or potentially relevant, unclear, or definitely not relevant to this review. We obtained the full‐text report for records classified as relevant or potentially relevant and unclear, two review authors independently assessed each reported study for inclusion or exclusion. We documented excluded studies after review of the full‐text report, with reasons for excluding (see <a href="./references#CD010520-sec-0101" title="">Characteristics of excluded studies</a> table). When a study's eligibility was unclear after full‐text review, we planned to contact the authors of the publication for clarification; however, it was not necessary to contact any authors for this purpose. We resolved discrepancies at all stages of assessment by discussion. </p> </section> <section id="CD010520-sec-0045"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data related to study characteristics, methodology, and outcomes using data forms developed by Cochrane Eyes and Vision for the purposes of this review. One review author entered the data into Review Manager 5 (<a href="./references#CD010520-bbs2-0068" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and a second review author verified the data entered. We resolved discrepancies in data extraction and data entry by discussion. We attempted to contact study investigators to obtain desired information when not reported or unclearly reported. Whenever no response or clarification was received within six weeks, we used the data available or reported the study results as unclear. </p> </section> <section id="CD010520-sec-0046"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed each included study for potential sources of systematic bias according to the methods described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010520-bbs2-0051" title="HigginsJP , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We considered the following parameters when assessing risk of bias. </p> <p> <ul id="CD010520-list-0005"> <li> <p>Selection bias (random sequence generation and allocation concealment before randomization).</p> </li> <li> <p>Performance bias (masking of study personnel).</p> </li> <li> <p>Detection bias (masking of outcome assessors).</p> </li> <li> <p>Attrition bias (completeness of follow‐up and intention‐to‐treat analysis).</p> </li> <li> <p>Reporting bias (selective outcome reporting).</p> </li> <li> <p>Other potential sources of bias (such as funding source when it could influence study methods or outcomes). </p> </li> </ul> </p> <p>Masking of study participants was not assessed at the study level because of the paired‐eye design of the included studies and the need to maintain the randomly assigned treatment of each eye. </p> <p>We assessed each study for each risk of bias parameter as having a 'low risk of bias,' a 'high risk of bias,' or an 'unclear risk of bias' (insufficient information to permit judgment of low or high risk). We attempted to contact study investigators whenever the methods were unclear or when additional information was needed to make an assessment. Whenever no response or clarification was received within six weeks, we assessed the study on the basis of available information. We resolved disagreements between review authors through discussion. </p> </section> <section id="CD010520-sec-0047"> <h4 class="title">Measures of treatment effect</h4> <p>We planned to report dichotomous outcomes as risk ratios (RR) with 95% confidence intervals (CI). We considered the proportions of participants with IOP less than 21 mmHg, development of glaucoma among suspects or other at risk, escalation of therapy, and adverse events as dichotomous outcomes. </p> <p>We planned to report continuous outcomes as mean differences (MD) between groups with 95% CIs. We considered mean IOP change, mean change in visual fields, optic nerve progression based on cup‐to‐disk ratio, mean change in best‐corrected visual acuity, physiologic measures of systemic absorption, quality of life outcomes, and cost‐effectiveness outcomes as continuous outcomes. </p> <p>Participant‐reported outcomes related to the ease, convenience, and comfort of instillation techniques may vary substantially; thus, we planned to assess these outcomes as reported by included studies. </p> </section> <section id="CD010520-sec-0048"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the eye in both included studies as both had used a within‐person, paired‐eye design. Investigators of one trial used a mixed model with two levels of clustering (participant and eye level) to account for the within‐person design (<a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>). The other study did not use a paired analysis to account for the correlation of characteristics and outcomes between the two eyes of a person and data were not reported in a manner that we could reanalyze outcomes in a paired analysis (<a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a>). We reported the data as provided in the study reports. </p> </section> <section id="CD010520-sec-0049"> <h4 class="title">Dealing with missing data</h4> <p>We planned to contact study investigators to ask for additional information when data were missing or incomplete. We set the response time at six weeks; when no reply was received in that time, we used the data available. </p> </section> <section id="CD010520-sec-0050"> <h4 class="title">Assessment of heterogeneity</h4> <p>Clinical heterogeneity among studies was assessed on the basis of characteristics of participants, including glaucoma status and length of time with glaucoma, age, race, and underlying comorbidities (such as arthritis). We also assessed heterogeneity among instillation methods, such as which type of method was used, how many medications were used, and whether medications were self‐administered or administered by a caregiver. We compared outcomes based on five elements (domain, specific measurement, specific metric, method of aggregation, and time points; <a href="./references#CD010520-bbs2-0069" title="SaldanhaIJ , DickersinK , WangX , LiT . Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability. PLoS One2014;9(10):e109400. ">Saldanha 2014</a>) to determine whether meta‐analysis was feasible. Due to lack of common outcomes reported in the trials, we were unable to combine data in meta‐analyses. If meta‐analysis is performed in future updates of the review, we will use the I<sup>2</sup> test to examine statistical heterogeneity. An I<sup>2</sup> value greater than 60% will be interpreted as indicating substantial statistical heterogeneity. If substantial statistical heterogeneity is present, we will not conduct a meta‐analysis but instead will report the study results independently. </p> </section> <section id="CD010520-sec-0051"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed selective outcome reporting bias at the individual study level. We compared outcomes that were specified a priori when study protocols or trial registry records were available, or outcomes that were measured as described in the methods section of a study report, with reported study results to classify studies as having high, low, or unclear risks of selective outcome reporting bias. We did not examine the symmetry of funnel plots to assess publication biases as described in the protocol for this review (<a href="./references#CD010520-bbs2-0077" title="XuL , WangX , WuM . Topical medication instillation techniques for glaucoma. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD010520] ">Xu 2013</a>), because we included only two studies in this review. </p> </section> <section id="CD010520-sec-0052"> <h4 class="title">Data synthesis</h4> <p>If additional studies are included in future updates to this review, we will combine results in a meta‐analysis when appropriate. We will use a fixed‐effect model for meta‐analyses that include fewer than three studies and a random‐effects model for meta‐analyses consisting of three or more studies. We will calculate summary MDs with 95% CIs for continuous outcomes and summary RRs with 95% CIs for dichotomous outcomes. For study results that are not adequate for meta‐analysis, we will summarize the overall treatment effects for each outcome as reported by each study. </p> </section> <section id="CD010520-sec-0053"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Because sufficient data were not available, we did not conduct planned subgroup analyses based on age (65 years and older), gender, race, type and number of medications, dose of medications, baseline glaucoma status (e.g., POAG, PACG, secondary glaucoma, glaucoma suspect, ocular hypertensive), and whether medications were instilled by the participant (self‐administered) or by a caregiver. </p> </section> <section id="CD010520-sec-0054"> <h4 class="title">Sensitivity analysis</h4> <p>We did not conduct planned sensitivity analyses to assess the impact of studies with high risk of bias, unpublished studies, and industry‐funded studies because insufficient data were available. We also planned to conduct sensitivity analyses for studies in which the unit of analysis was the eyes rather than the participant. </p> <section id="CD010520-sec-0055"> <h5 class="title">'Summary of findings' table</h5> <p>We used the GRADE method to assess the certainty of evidence for each outcome reported in this review (<a href="./references#CD010520-bbs2-0048" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 15 January 2017. Hamilton (ON): GRADE Working Group, McMaster University, 2014. ">GRADEpro 2014</a>). Two review authors independently judged each outcome as very low‐, low‐, moderate‐, or high‐certainty according to the following five criteria: risk of bias, indirectness, heterogeneity, imprecision (wide CIs), and publication bias. We resolved any discrepancy by discussion. We produced a 'Summary of findings' table, which presents the comparative effects between treatments, to summarize the following main outcomes evaluated in this review: proportion of participants with IOP less than 21 mmHg; mean IOP change from baseline; participant‐reported outcomes related to the ease, convenience, and comfort of instillation; physiologic measurements of systemic absorption, escalation of therapy, mean change in visual fields, and adverse events. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010520-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010520-sec-0056"></div> <section id="CD010520-sec-0057"> <h3 class="title">Description of studies</h3> <section id="CD010520-sec-0058"> <h4 class="title">Results of the search</h4> <p>The electronic searches yielded 12,335 unique records after removing duplicates (<a href="#CD010520-fig-0001">Figure 1</a>). We excluded 12,298 records by screening titles and abstracts, and 31 records (26 studies) after reviewing 37 full‐text reports. We included two trials (three reports) in this review (<a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a>; <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>), identified two ongoing trials (<a href="./references#CD010520-bbs2-0030" title="NCT01416415 . Glaucoma eye drop instillation: impact of education. clinicaltrials.gov/ct2/show/NCT01416415 Date first received: 11 August 2011. ">NCT01416415</a>; <a href="./references#CD010520-bbs2-0031" title="NCT02697318 . Evaluation of a new method for instilling eye drops. clinicaltrials.gov/ct2/show/NCT02697318 Date first received: 29 February 2016. ">NCT02697318</a>), and left one trial report as awaiting assessment until we can confirm whether the trial was initiated or completed (<a href="./references#CD010520-bbs2-0029" title="NCT01417689 . Eyedrop instillation technique: a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01417689 Date first received: 15 August 2011. ">NCT01417689</a>). We identified no additional eligible trials from searching other sources. </p> <div class="figure" id="CD010520-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010520-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010520.pub2/media/CDSR/CD010520/image_n/nCD010520-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010520-sec-0059"> <h4 class="title">Included studies</h4> <section id="CD010520-sec-0060"> <h5 class="title">Types of participants</h5> <p>We included two within‐person, RCTs (122 eyes of 61 participants); one trial was conducted in Italy (20 eyes of 10 participants) and one in the US (102 eyes of 51 participants). Both trials included men and women with bilateral glaucoma or ocular hypertension. One trial included only participants currently using prostaglandin monotherapy (latanoprost, travoprost, or bimatoprost) to reduce IOP (<a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>), while the other trial excluded past or current use of topical prostaglandins or prostamides (<a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a>). </p> </section> <section id="CD010520-sec-0061"> <h5 class="title">Types of interventions</h5> <p>Participants in both trials received prostaglandin monotherapy during the study; bimatoprost only in <a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a> and latanoprost, travoprost, or bimatoprost in <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>. However, the instillation technique under investigation differed between the two trials. In <a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a>, each participant wiped one eye with an absorbent pad after self‐administration of drops to minimize absorption of the eye drops into the skin but did not wipe the contralateral eye after instillation. In <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>, participants were randomized to keep one eye closed for either one or three minutes after self‐administration of drops to increase the ocular effect of the eye drops. The fellow eyes of participants served as controls in both trials. </p> </section> <section id="CD010520-sec-0062"> <h5 class="title">Types of outcomes</h5> <p>The outcomes assessed by each of the trials reflected the trial authors research question posed by the trial investigators and the type of instillation technique under investigation. The authors of <a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a> aimed to evaluate the dermatologic effects of removing excess fluid during and after instillation of bimatoprost drops. Therefore, the outcomes assessed in the trial did not include IOP or vision‐related measures and focused only on known dermatologic effects of prostaglandins (eyelash length, eyelash growth, skin hypertrichosis, and skin hyperpigmentation). Follow‐up examinations to assess outcomes from this trial were at one, three, and four months. </p> <p>The authors of <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a> were interested in the effect of ELC on lowering IOP in chronic users of prostaglandin eye drops. IOP was the only outcome assessed in this trial and was measured one hour, one day, and final follow‐up (7 to 14 days). Subgroup analysis was reported for participants randomized to one or three minutes of POAG (i.e. one minute versus fellow eye and three minutes versus fellow eye). </p> <p>Neither trial reported the proportion of participants with IOP less than 21 mmHg; participant‐reported outcomes related to the ease, convenience, and comfort of instillation techniques; physiologic measurements of systemic absorption; escalation of therapy (such as added medications, laser trabeculoplasty, surgery, or a combination of these); mean change in visual fields; optic nerve progression (measured by mean change in cup/disk ratio); mean change in best‐corrected visual acuity; development of glaucoma among baseline glaucoma suspects; quality of life outcomes; or cost‐effectiveness outcomes. No data from either trial were reported at follow‐up times of more than four months. </p> </section> </section> <section id="CD010520-sec-0063"> <h4 class="title">Excluded studies</h4> <p>We excluded 26 studies after review of the full‐text reports. Reasons for excluding each study are presented in the <a href="./references#CD010520-sec-0101" title="">Characteristics of excluded studies</a> table. In summary, 11 studies did not use a randomized design, 20 studies did not evaluate interventions under the scope of this review, and two studies did not include participants with glaucoma. We excluded seven studies for more than one reason. </p> </section> </section> <section id="CD010520-sec-0064"> <h3 class="title">Risk of bias in included studies</h3> <p>We provide details of the 'Risk of bias' assessment for each trial in the <a href="./references#CD010520-sec-0100" title="">Characteristics of included studies</a> table and a summary in <a href="#CD010520-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD010520-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD010520-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010520.pub2/media/CDSR/CD010520/image_n/nCD010520-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010520-sec-0065"> <h4 class="title">Allocation</h4> <p>We assessed <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a> at low risk of selection bias because the randomization was computer generated and allocation of treatment assignments were concealed by use of sequentially numbered, opaque, sealed envelopes that were opened only at the time of randomization. <a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a> used computer‐generated randomization; however, no methods were reported in regards to allocation concealment before randomization. </p> <section id="CD010520-sec-0066"> <h5 class="title">Masking (performance bias and detection bias)</h5> <p>We assessed both trials at high risk of performance bias because masking of participants was not feasible with the interventions under investigation and there was the possibility of a cross‐over (contamination) effect between groups due to the paired‐eye design of the studies (i.e. participants may have applied eye drops to both eyes in the same manner). We assessed <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a> at low risk of detection bias because outcome assessors were masked to treatment assignment and <a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a> at unclear risk because it was not reported whether study personnel who collected and measured eyelashes were masked. However, assessors or skin‐related outcomes were masked in <a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a>. </p> </section> </section> <section id="CD010520-sec-0067"> <h4 class="title">Incomplete outcome data</h4> <p>In both trials, all participants completed the study and eyes were analyzed as randomized. Therefore, we assessed both trials had low or no risk of attrition bias. </p> </section> <section id="CD010520-sec-0068"> <h4 class="title">Selective reporting</h4> <p>We assessed both trials at low risk of reporting bias. Although there were minor differences between the trial registry record and journal publication for <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>, both reports indicated that change in IOP was the primary and only outcome of interest. There was no protocol or trial registry record found for <a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a>; however, all outcome measures that were described in the methods section of the study publication were reported in the results section. </p> </section> <section id="CD010520-sec-0069"> <h4 class="title">Other potential sources of bias</h4> <p>We identified no other potential sources of bias for <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>. The authors of <a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a> did not report sources of funding or declare no financial interests; therefore, we assessed this trial at unclear risk of other potential sources of bias. </p> </section> </section> <section id="CD010520-sec-0070"> <h3 class="title" id="CD010520-sec-0070">Effects of interventions</h3> <p>See: <a href="./full#CD010520-tbl-0001"><b>Summary of findings for the main comparison</b> Topical medication instillation techniques for glaucoma</a> </p> <p>We performed no meta‐analyses for this review as the included trials did not evaluate the same instillation techniques or report the same outcomes. <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a> reported only mean change in IOP, which compared POAG versus no POAG after instilling prostaglandin drops in 102 eyes of 51 participants. <a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a> reported only outcomes related to dermatologic adverse events among 20 eyes of 10 participants to test the utility of removing excess fluid during and after instillation of bimatoprost drops. </p> <p>There were no data available for the other outcomes that we specified in the protocol for this review. Neither trial reported outcomes at one year, the primary follow‐up time specified in our protocol from the review. </p> <section id="CD010520-sec-0071"> <h4 class="title">Mean change in intraocular pressure</h4> <p>One trial reported outcomes for mean change in IOP from baseline (<a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>). At one to two weeks' follow‐up, the MD in IOP change was ‐0.33 mmHg (95% CI ‐0.8 to 1.5; 51 participants) when comparing the ELC group with the no ELC group (estimated using a mixed model to account for the within‐person design). Results of the MD in IOP change from baseline were similar when analyzing by subgroups of ELC for one minute (0.41 mmHg, 95% CI ‐1.0 to 1.9; 25 participants) and three minutes (0.86 mmHg, 95% CI ‐0.6 to 2.3; 26 participants). We did not consider the mean difference in IOP change between to be clinically meaningful. We graded the certainty of evidence as moderate, downgrading one level for risk of performance bias. </p> </section> <section id="CD010520-sec-0072"> <h4 class="title">Adverse events</h4> <p>One trial reported outcomes related to adverse events (<a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a>). At four months' follow‐up, eyelashes were shorter among eyes that participants had wiped to remove excess fluid compared with fellow eyes that were not wiped (MD ‐1.70 mm, 95% CI ‐3.46 to 0.06; 10 participants). Furthermore, 5 of 10 eyes in the fluid removal group compared with 9 of 10 eyes in the no removal group experienced eyelash growth of more than 1.5 mm (RR 0.11, 95% CI 0.01 to 1.24). We graded the certainty of evidence as low, downgrading one level for risk of performance and detection bias and one level for imprecision. </p> <p><a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a> also reported adverse events on the skin around the eyes at four months' follow‐up. Fewer eyes showed skin hyperpigmentation in the eyelid region towards the nose in the fluid removal group (1 of 10) compared with the no removal group (6 of 10) (RR 0.07, 95% CI 0.01 to 0.84). However, the difference was not as prominent in the eyelid region towards the temples (4 of 10 eyes in the fluid removal group and 6 of 10 eyes in the no removal group; RR 0.44, 95% CI 0.07 to 2.66). The proportion with hypertrichosis (excessive hair growth) was 6 of 10 eyes in both groups (RR 1.00, 95% CI 0.17 to 5.98). We graded the certainty of evidence as low, downgrading one level for risk of performance bias and one level for imprecision. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010520-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010520-sec-0073"></div> <section id="CD010520-sec-0074"> <h3 class="title" id="CD010520-sec-0074">Summary of main results</h3> <p>Our comprehensive search for RCTs investigating the effectiveness of proposed topical medication instillation techniques in the management of glaucoma included only two studies (<a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a>; <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>). The two studies randomly selected one eye of 61 participants who received bilateral prostaglandin monotherapy to instill a topical medication using a potentially beneficial technique to reduce adverse events or increase IOP‐lowering effects, and the fellow eye acted as the within‐person control. </p> <p>One study evaluated the effect of removing excess fluid to minimize dermatologic adverse events of bimatoprost 0.03% topical therapy. In <a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a>, there was a smaller proportion of regional dermatologic skin changes in the eyes when removing excess fluid compared with not removing excess fluid. However, reducing the drop‐skin contact during drop instillation minimized the incidence of regional dermatologic adverse events, but not for the entire periocular area. </p> <p>One study investigates the effect of ELC to enhance the IOP‐lowering effect after self‐administration of prostaglandin drops on lowering IOP. In <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>, there was no additional IOP reduction in the ELC group. </p> </section> <section id="CD010520-sec-0075"> <h3 class="title" id="CD010520-sec-0075">Overall completeness and applicability of evidence</h3> <p>The two studies included in our review evaluated two topical medication instillation techniques for prostaglandin analog monotherapy (<a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a>; <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>), which is the most frequently prescribed initial agent for lowering IOP (<a href="./references#CD010520-bbs2-0046" title="Garway‐HeathDF , CrabbDP , BunceC , LascaratosG , AmalfitanoF , AnandN , et al. Latanoprost for open‐angle glaucoma (UKGTS): a randomised, multicentre, placebo‐controlled trial. Lancet2015;385(9975):1295‐304. ">Garway‐Heath 2015</a>; <a href="./references#CD010520-bbs2-0062" title="McKinnonSJ , GoldbergLD , PeeplesP , WaltJG , BramleyTJ . Current management of glaucoma and the need for complete therapy. American Journal of Managed Care2008;14(1 Suppl):S20‐7. ">McKinnon 2008</a>). Dermatologic adverse events from topical prostaglandins are well documented and may not apply to other types of IOP‐lowering drug classes. It also is unknown whether the effect of topical medication instillation techniques differs among different drug classes. </p> <p>We found no evidence for other topical medication instillation techniques (e.g. NLO). For beta‐blockers, such as timolol, commonly associated adverse events are cardiovascular and respiratory complications. Thus, preventive measures may be aimed to reduce systemic absorption, therefore, evaluation of NLO would be of more interest than other instillation techniques for many IOP‐lowering agents. The effectiveness of punctal plugs (plugs inserted into the tear duct to block the medications from draining from the eye and to reduce systemic absorption), which were not included in the scope of this review, also would be of interest. </p> <p><a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a> and <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a> were conducted in Italy and the US, respectively. These regions have well‐developed healthcare systems; thus, it is unknown how the estimates from these studies may apply to cases of glaucoma in countries with less developed and lower income health systems. For example, relatively cheaper agents, such as beta‐blockers, are the most commonly used antiglaucoma agents in some countries. Also, POAG is the most common glaucoma type in the US; participants in <a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a> were predominantly white people with the baseline IOP of 18 mmHg. It is unknown how outcome estimates from this study may apply to cases of glaucoma in Asian countries where, for example, PACG is more common and has higher baseline IOP levels. Absolute level of changes in IOP differ by baseline levels in that eyes with higher IOP levels at baseline have more potential to be reduced than eyes with lower IOP levels at baseline. </p> </section> <section id="CD010520-sec-0076"> <h3 class="title" id="CD010520-sec-0076">Quality of the evidence</h3> <p>One study included in this review was well designed, reported clearly, and had low risk of bias overall except it had high performance bias; thus, we assessed the certainty of evidence from this review as moderate (<a href="./references#CD010520-bbs2-0002" title="MaulEA , FriedmanDS , QuigleyHA , JampelHD . Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. British Journal of Ophthalmology2012;96(2):250‐3. ">Maul 2012</a>). However, it is important to note that follow‐up was brief at only one to two weeks, which may be too short to observe therapeutic differences between groups and allow for cyclical fluctuations in IOP. </p> <p>One study provided low‐certainty evidence for dermatologic adverse events (downgraded for performance bias, detection bias, imprecision, or a combination of these). Although estimates were imprecise, <a href="./references#CD010520-bbs2-0001" title="CentofantiM , OddoneF , ChimentiS , TangaL , CitarellaL , ManniG . Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. American Journal of Ophthalmology2006;142(6):1059‐60. ">Centofanti 2006</a> showed that reducing the drop‐skin contact may minimize the incidence of regional dermatologic adverse events and eyelash growth. </p> </section> <section id="CD010520-sec-0077"> <h3 class="title" id="CD010520-sec-0077">Potential biases in the review process</h3> <p>We used standard Cochrane methodological procedures to minimize potential biases in the review process. We reported all outcomes that were specified in the protocol for this review or reported that no data were available for specified outcomes. </p> </section> <section id="CD010520-sec-0078"> <h3 class="title" id="CD010520-sec-0078">Agreements and disagreements with other studies or reviews</h3> <p>Although non‐randomized studies suggest that NLO or ELC may be used to reduce systemic absorption (<a href="./references#CD010520-bbs2-0011" title="FlachAJ . The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies. Transactions of the American Ophthalmological Society2008;106:138‐45. ">Flach 2008</a>; <a href="./references#CD010520-bbs2-0053" title="KailaT , HuupponenR , SalminenL . Effects of eyelid closure and nasolacrimal duct occlusion on the systemic absorption of ocular timolol in human subjects. Journal of Ocular Pharmacology1986;2(4):365‐9. ">Kaila 1986</a>; <a href="./references#CD010520-bbs2-0019" title="PassoMS , PalmerEA , VanBuskirkEM . Plasma timolol in glaucoma patients. Ophthalmology1984;91(11):1361‐3. ">Passo 1984</a>; <a href="./references#CD010520-bbs2-0028" title="ZimmermanTJ , KoonerKS , KandarakisAS , ZieglerLP . Improving the therapeutic index of topically applied ocular drugs. Archives of Ophthalmology1984;102(4):551‐3. ">Zimmerman 1984</a>) and enhance ocular penetration (<a href="./references#CD010520-bbs2-0043" title="EllisPP , WuPY , PfoffDS , BloedowDC , RiegelMR . Effect of nasolacrimal occlusion on timolol concentrations in the aqueous humor of the human eye. Journal of Pharmaceutical Sciences1992;81(3):219‐20. ">Ellis 1992</a>; <a href="./references#CD010520-bbs2-0011" title="FlachAJ . The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies. Transactions of the American Ophthalmological Society2008;106:138‐45. ">Flach 2008</a>; <a href="./references#CD010520-bbs2-0045" title="FraunfelderFT . Extraocular fluid dynamics: how best to apply topical ocular medication. Transactions of the American Ophthalmological Society1976;74:457‐87. ">Fraunfelder 1976</a>; <a href="./references#CD010520-bbs2-0028" title="ZimmermanTJ , KoonerKS , KandarakisAS , ZieglerLP . Improving the therapeutic index of topically applied ocular drugs. Archives of Ophthalmology1984;102(4):551‐3. ">Zimmerman 1984</a>) of the topical agents, the evidence of effects on IOP control is inconclusive. As one type of topical instillation techniques, ELC is thought to increase the contact time between the ocular area and drops, which in turn, aims to improve ocular bioavailability. However, the additional bioavailability by enhanced ocular penetration of the medicine by ELC has not been shown to bring about increased IOP‐lowing effects that can be detected clinically. </p> <p>This review included one RCT which directly measured the IOP‐lowering of ELC in chronic users of prostaglandin eye drops for the treatment of glaucoma. The lack of significant differences between the intervention group and the control group concurs with reports by other non‐randomized studies and clinical observations with NLO (<a href="./references#CD010520-bbs2-0014" title="HuangTC , LeeDA . Punctal occlusion and topical medications for glaucoma. American Journal of Ophthalmology1989;107(2):151‐5. ">Huang 1989</a>; <a href="./references#CD010520-bbs2-0022" title="SharirM , ZimmermanTJ . Effect of nasolacrimal occlusion on dose and duration of action of tropical ocular hypotensive agents. Advances in Therapy1993;10(2):74‐85. SharirM , ZimmermanTJ . Nasolacrimal occlusion improves the therapeutic index of antiglaucoma medications. Journal of the Association for Academic Minority Physicians1994;5(2):62‐7. ZimmermanTJ , SharirM , NardinGF , FuquaM . Therapeutic index of epinephrine and dipivefrin with nasolacrimal occlusion. American Journal of Ophthalmology1992;114(1):8‐13. ZimmermanTJ , SharirM , NardinGF , FuquaM . Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion. American Journal of Ophthalmology1992;114(1):1‐7. ">Sharir 1994</a>). </p> <p>The latest American Academy of Ophthalmology's Preferred Practice Pattern on Primary Open Angle Glaucoma (<a href="./references#CD010520-bbs2-0032" title="American Academy of Ophthalmology (AAO) Preferred Practice Pattern GlaucomaPanel . Primary Open‐Angle Glaucoma PPP ‐ 2015. www.aao.org/preferred‐practice‐pattern/primary‐open‐angle‐glaucoma‐ppp‐2015 (accessed 8 February 2017). ">AAO 2015</a>) recommends educating people using eye drops to lower IOP about ELC and NLO techniques to reduce systemic absorption; however, there was no evidence cited that either supported or refuted that ELC alone, NLO alone, or both are effective means to lower IOP. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010520-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/media/CDSR/CD010520/urn:x-wiley:14651858:media:CD010520:CD010520-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/media/CDSR/CD010520/image_t/tCD010520-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010520-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010520.pub2/media/CDSR/CD010520/image_n/nCD010520-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/media/CDSR/CD010520/image_n/nCD010520-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010520-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/media/CDSR/CD010520/urn:x-wiley:14651858:media:CD010520:CD010520-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/media/CDSR/CD010520/image_t/tCD010520-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD010520-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010520.pub2/media/CDSR/CD010520/image_n/nCD010520-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/media/CDSR/CD010520/image_n/nCD010520-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010520-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Topical medication instillation techniques for glaucoma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Topical medication instillation techniques for glaucoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> participants with glaucoma or ocular hypertension </p> <p><b>Settings:</b> ophthalmology clinics </p> <p><b>Intervention:</b> any intervention aimed to increase effectiveness or reduce adverse events when using topical medications (e.g. eyelid closure, nasolacrimal occlusion, removal of excess fluid after instillation) </p> <p><b>Comparison:</b> no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No intervention</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Instillation intervention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants with IOP &lt; 21 mmHg</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean IOP change from baseline</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 trial reported that reduction of IOP was similar in eyes when the eyelid was kept closed for up to 3 minutes after instillation of drops than fellow eyes that did not practice eyelid closure at 2 weeks (MD ‐0.33 mmHg, 95% CI ‐0.8 to 1.5; 51 participants); moderate‐certainty evidence.<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported outcomes related to the ease, convenience, and comfort of instillation</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physiologic measurements of systemic absorption</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Escalation of therapy</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in visual fields</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>at 1 year' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 trial with up to 4 months' follow‐up reported that eyelashes were shorter among eyes when participants had wiped to remove excess fluid compared with fellow eyes that were not wiped (MD ‐1.70 mm, 95% CI ‐3.46 to 0.06; 10 participants) and fewer eyes had eyelash growth of &gt; 1.5 mm when wiping compared with not wiping (RR 0.11, 95% CI 0.01 to 1.24); low‐certainty evidence.<sup>1,2</sup> </p> <p>This same trial also reported that fewer eyes showed skin hyperpigmentation in the eyelid region towards the nose when wiping compared with not wiping (RR 0.07, 95% CI 0.01 to 0.84); however, the difference was not certain when assessing skin hyperpigmentation in the eyelid region towards the temples (RR 0.44, 95% CI 0.07 to 2.66) or hair growth on the skin around the eye (RR 1.00, 95% CI 0.17 to 5.98); low‐certainty evidence.<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the control group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>MD:</b> mean difference; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for risk of performance, detection bias, or both.<br/> <sup>2</sup>Downgraded one level for imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Topical medication instillation techniques for glaucoma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010520-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Commonly reported adverse events of medical glaucoma treatments</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Drug class</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Ocular adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Systemic adverse events</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Alpha‐agonists (e.g. apraclonidine, brimonidine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allergic reactions</p> <p>Blurred vision</p> <p>Burning/stinging/discomfort</p> <p>Follicular conjunctival response</p> <p>Hyperemia</p> <p>Itching</p> <p>Photophobia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allergic reactions</p> <p>Drowsiness</p> <p>Dry mouth</p> <p>Fatigue</p> <p>Headache</p> <p>Hypotension</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beta‐blockers (e.g. betaxolol, carteolol, levobunolol, timolol)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allergy</p> <p>Blurred vision</p> <p>Burning/stinging/discomfort</p> <p>Corneal erosion</p> <p>Dry eyes</p> <p>Hyperemia</p> <p>Hypotony</p> <p>Ptosis</p> <p>Superficial punctate keratitis</p> <p>Visual disturbances</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bradycardia</p> <p>Depression</p> <p>Dizziness or light‐headedness</p> <p>Fatigue</p> <p>Headache</p> <p>Indigestion or heart pain</p> <p>Insomnia</p> <p>Joint pain</p> <p>Nausea</p> <p>Shortness of breath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Carbonic anhydrase inhibitors (e.g. acetazolamide, brinzolamide, dorzolamide)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allergy</p> <p>Blurred vision</p> <p>Burning/stinging/discomfort</p> <p>Dry eyes</p> <p>Foreign body sensation</p> <p>Hyperemia</p> <p>Photophobia</p> <p>Superficial punctate keratitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allergic reactions</p> <p>Bitter or metallic taste</p> <p>Dizziness</p> <p>Fatigue</p> <p>Gastrointestinal distress</p> <p>Headache</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Parasympathomimetics (e.g. carbachol, pilocarpine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blurred vision</p> <p>Burning/stinging/discomfort</p> <p>Eyelid twitching</p> <p>Hyperemia</p> <p>Itching</p> <p>Increased tearing</p> <p>Poor vision in dim light</p> <p>Visual disturbances</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dizziness</p> <p>Headache</p> <p>Hypoglycemia</p> <p>Increased saliva</p> <p>Increased sweating</p> <p>Nausea</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prostaglandin analogues (e.g. bimatoprost, latanoprost, travoprost)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blurred vision</p> <p>Burning/stinging/discomfort</p> <p>Dry eyes</p> <p>Eyelash growth</p> <p>Foreign body sensation</p> <p>Hyperemia</p> <p>Increased tearing</p> <p>Iris/skin discoloration</p> <p>Itching</p> <p>Photophobia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cold symptoms</p> <p>Exacerbation of asthma</p> <p>Facial rash</p> <p>Joint or muscle pain</p> <p>Upper respiratory infection</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Commonly reported adverse events of medical glaucoma treatments</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010520.pub2/full#CD010520-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010520.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010520-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010520-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010520-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD010520-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010520-note-0009">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010520\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010520\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010520\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010520\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010520\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010520.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010520.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010520.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010520.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010520.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718944636"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010520.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718944639"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010520.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ddcb6b9021be5',t:'MTc0MDcxODk0NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 